Roche Holding Ltd. (ROG) Given a CHF 230 Price Target by Kepler Capital Markets Analysts

Roche Holding Ltd. (VTX:ROG) has been given a CHF 230 price target by stock analysts at Kepler Capital Markets in a report issued on Monday. The firm presently has a “neutral” rating on the healthcare company’s stock.

Other equities analysts have also issued research reports about the stock. Deutsche Bank AG set a CHF 273 price target on shares of Roche Holding and gave the stock a “buy” rating in a report on Tuesday, June 6th. Morgan Stanley set a CHF 290 target price on shares of Roche Holding and gave the company a “buy” rating in a report on Monday, May 29th. Jefferies Group LLC set a CHF 305 target price on shares of Roche Holding and gave the company a “buy” rating in a report on Monday, May 29th. Goldman Sachs Group, Inc. (The) set a CHF 335 target price on shares of Roche Holding and gave the company a “buy” rating in a report on Friday, May 26th. Finally, J P Morgan Chase & Co restated a “buy” rating on shares of Roche Holding in a report on Saturday, May 20th. One analyst has rated the stock with a sell rating, six have given a hold rating and eight have assigned a buy rating to the stock. Roche Holding has an average rating of “Hold” and a consensus price target of CHF 271.57.

Shares of Roche Holding (VTX ROG) opened at 241.40 on Monday. Roche Holding has a 12 month low of CHK 218.30 and a 12 month high of CHK 273.00. The firm’s 50 day moving average is CHK 243.57 and its 200 day moving average is CHK 252.51. The company has a market cap of CHK 205.98 billion and a PE ratio of 21.43.

COPYRIGHT VIOLATION NOTICE: “Roche Holding Ltd. (ROG) Given a CHF 230 Price Target by Kepler Capital Markets Analysts” was published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://stocknewstimes.com/2017/09/11/roche-holding-ltd-rog-given-a-chf-230-price-target-by-kepler-capital-markets-analysts.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)




Receive News & Ratings for Roche Holding Ltd. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Roche Holding Ltd. and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

eleven − five =